ASRW:XETRA:XETRA-BNP Paribas Easy MSCI World ESG Filtered Min TE UCITS ETF Cap USD (USD)

ETF | Others |

Last Closing

USD 14.718

Change

+0.09 (+0.63)%

Market Cap

N/A

Volume

4.30K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict
Created with Highstock 5.0.6

Very Bullish

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
ASRW:XETRA
Relative Returns (From:    To: 2025-01-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CA1:XETRA Circus SE

-0.20 (-1.03%)

USD 0.51B
7V0:XETRA Darwin AG

N/A

USD 0.08B
TY3S:XETRA WisdomTree US Treasuries 10Y 3..

+0.93 (+0.89%)

N/A
AXTZ:XETRA 21Shares Tezos staking ETP

-0.08 (-1.55%)

N/A
42FB:XETRA AI/ML Innovations Inc.

-0.01 (-14.58%)

N/A
ABCH:XETRA 21Shares Bitcoin Cash ETP

-0.90 (-6.58%)

N/A
8PSB:XETRA Invesco Physical Markets PLC O

-0.08 (-0.28%)

N/A
BTIC:XETRA Invesco Physical Bitcoin ETN E..

-0.91 (-1.01%)

N/A
2BTD:XETRA 2BTD

-0.41 (-1.27%)

N/A
8PSC:XETRA Source Physical Palladium P

-0.53 (-0.59%)

N/A

ETFs Containing ASRW:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.34% 59% D- 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.34% 58% F 56% F
Trailing 12 Months  
Capital Gain 18.90% 71% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.90% 70% C- 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.84% 71% C- 69% C-
Dividend Return 11.84% 70% C- 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.87% 54% F 63% D
Risk Adjusted Return 99.71% 87% B+ 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike